Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. - Blankenship S; Flueckiger BV; Caleb G; Bailey J; Baker E; Garcia B; Krick S (Therapeutic advances in respiratory disease, 2026)